Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 101–150 of 2,735 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06579196	Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1	active not recruiting	Phase 1 / Phase 2	45	University of NebraskaOTHER	1	Sep 25, 2026	clinicaltrials
NCT06736717	Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer(PANCONVA)	active not recruiting	Phase 1 / Phase 2	16	University of Kansas Medical CenterOTHER	1	Sep 25, 2026